AstraZeneca PLC — Director's Dealing 2016

Nov 7, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ALBIREO PHARMA, INC. (ALBO)
CIK: 0001322505
Period of Report: 2016-11-03

Reporting Person: ASTRAZENECA PLC (10% Owner)
Reporting Person: ASTRAZENECA AB (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1008141	Indirect

Footnotes

F1: Represents shares of common stock of Albireo Pharma, Inc. (the "Issuer"), formerly known as Biodel Inc., issued in the share exchange transaction that was completed on November 3, 2016 pursuant to an Amended and Restated Share Exchange Agreement, dated as of July 13, 2016, by and among Biodel Inc., Albireo Limited ("Albireo") and the holders of Albireo shares and notes convertible into Albireo shares.

F2: AstraZeneca AB is a wholly-owned subsidiary of AstraZeneca PLC. AstraZeneca PLC may be deemed to beneficially own the shares held by AstraZeneca AB, but disclaims beneficial ownership except to the extent of its pecuniary interest therein, if any.